Cargando…

Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein

AIMS/HYPOTHESIS: Endothelial cells (ECs) and smooth muscle cells (SMCs) play key roles in the development of intimal hyperplasia in saphenous vein (SV) bypass grafts. In diabetic patients, insulin administration controls hyperglycaemia but cardiovascular complications remain. Insulin is synthesised...

Descripción completa

Detalles Bibliográficos
Autores principales: Mughal, R. S., Scragg, J. L., Lister, P., Warburton, P., Riches, K., O’Regan, D. J., Ball, S. G., Turner, N. A., Porter, K. E.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892072/
https://www.ncbi.nlm.nih.gov/pubmed/20461358
http://dx.doi.org/10.1007/s00125-010-1736-6
_version_ 1782182921068609536
author Mughal, R. S.
Scragg, J. L.
Lister, P.
Warburton, P.
Riches, K.
O’Regan, D. J.
Ball, S. G.
Turner, N. A.
Porter, K. E.
author_facet Mughal, R. S.
Scragg, J. L.
Lister, P.
Warburton, P.
Riches, K.
O’Regan, D. J.
Ball, S. G.
Turner, N. A.
Porter, K. E.
author_sort Mughal, R. S.
collection PubMed
description AIMS/HYPOTHESIS: Endothelial cells (ECs) and smooth muscle cells (SMCs) play key roles in the development of intimal hyperplasia in saphenous vein (SV) bypass grafts. In diabetic patients, insulin administration controls hyperglycaemia but cardiovascular complications remain. Insulin is synthesised as a pro-peptide, from which C-peptide is cleaved and released into the circulation with insulin; exogenous insulin lacks C-peptide. Here we investigate modulation of human SV neointima formation and SV-EC and SV-SMC function by insulin and C-peptide. METHODS: Effects of insulin and C-peptide on neointima formation (organ cultures), EC and SMC proliferation (cell counting), EC migration (scratch wound), SMC migration (Boyden chamber) and signalling (immunoblotting) were examined. A real-time RT–PCR array identified insulin-responsive genes, and results were confirmed by real-time RT–PCR. Targeted gene silencing (siRNA) was used to assess functional relevance. RESULTS: Insulin (100 nmol/l) augmented SV neointimal thickening (70% increase, 14 days), SMC proliferation (55% increase, 7 days) and migration (150% increase, 6 h); effects were abrogated by 10 nmol/l C-peptide. C-peptide did not affect insulin-induced Akt or extracellular signal-regulated kinase signalling (15 min), but array data and gene silencing implicated sterol regulatory element binding transcription factor 1 (SREBF1). Insulin (1–100 nmol/l) did not modify EC proliferation or migration, whereas 10 nmol/l C-peptide stimulated EC proliferation by 40% (5 days). CONCLUSIONS/INTERPRETATION: Our data support a causative role for insulin in human SV neointima formation with a novel counter-regulatory effect of proinsulin C-peptide. Thus, C-peptide can limit the detrimental effects of insulin on SMC function. Co-supplementing insulin therapy with C-peptide could improve therapy in insulin-treated patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-1736-6) contains supplementary material, which is available to authorised users.
format Text
id pubmed-2892072
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-28920722010-07-21 Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein Mughal, R. S. Scragg, J. L. Lister, P. Warburton, P. Riches, K. O’Regan, D. J. Ball, S. G. Turner, N. A. Porter, K. E. Diabetologia Article AIMS/HYPOTHESIS: Endothelial cells (ECs) and smooth muscle cells (SMCs) play key roles in the development of intimal hyperplasia in saphenous vein (SV) bypass grafts. In diabetic patients, insulin administration controls hyperglycaemia but cardiovascular complications remain. Insulin is synthesised as a pro-peptide, from which C-peptide is cleaved and released into the circulation with insulin; exogenous insulin lacks C-peptide. Here we investigate modulation of human SV neointima formation and SV-EC and SV-SMC function by insulin and C-peptide. METHODS: Effects of insulin and C-peptide on neointima formation (organ cultures), EC and SMC proliferation (cell counting), EC migration (scratch wound), SMC migration (Boyden chamber) and signalling (immunoblotting) were examined. A real-time RT–PCR array identified insulin-responsive genes, and results were confirmed by real-time RT–PCR. Targeted gene silencing (siRNA) was used to assess functional relevance. RESULTS: Insulin (100 nmol/l) augmented SV neointimal thickening (70% increase, 14 days), SMC proliferation (55% increase, 7 days) and migration (150% increase, 6 h); effects were abrogated by 10 nmol/l C-peptide. C-peptide did not affect insulin-induced Akt or extracellular signal-regulated kinase signalling (15 min), but array data and gene silencing implicated sterol regulatory element binding transcription factor 1 (SREBF1). Insulin (1–100 nmol/l) did not modify EC proliferation or migration, whereas 10 nmol/l C-peptide stimulated EC proliferation by 40% (5 days). CONCLUSIONS/INTERPRETATION: Our data support a causative role for insulin in human SV neointima formation with a novel counter-regulatory effect of proinsulin C-peptide. Thus, C-peptide can limit the detrimental effects of insulin on SMC function. Co-supplementing insulin therapy with C-peptide could improve therapy in insulin-treated patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-1736-6) contains supplementary material, which is available to authorised users. Springer-Verlag 2010-05-12 2010 /pmc/articles/PMC2892072/ /pubmed/20461358 http://dx.doi.org/10.1007/s00125-010-1736-6 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Mughal, R. S.
Scragg, J. L.
Lister, P.
Warburton, P.
Riches, K.
O’Regan, D. J.
Ball, S. G.
Turner, N. A.
Porter, K. E.
Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
title Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
title_full Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
title_fullStr Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
title_full_unstemmed Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
title_short Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
title_sort cellular mechanisms by which proinsulin c-peptide prevents insulin-induced neointima formation in human saphenous vein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892072/
https://www.ncbi.nlm.nih.gov/pubmed/20461358
http://dx.doi.org/10.1007/s00125-010-1736-6
work_keys_str_mv AT mughalrs cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT scraggjl cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT listerp cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT warburtonp cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT richesk cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT oregandj cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT ballsg cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT turnerna cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein
AT porterke cellularmechanismsbywhichproinsulincpeptidepreventsinsulininducedneointimaformationinhumansaphenousvein